Zug, Switzerland (ots/PRNewswire) - - Libtayo (cemiplimab) is a leading PD-1 inhibitor that has shown efficacy in the treatment of certain patients with cutaneous squamous cell carcinoma, advanced basal cell carcinoma, advanced non-small cell lung cancer and advanced cervical cancer, and is approved by regulatory ...
Petach Tikvah, Israel and Zug, Switzerland (ots/PRNewswire) - Sarah Otten will lead Medison's Americas region covering Canada and Latin America. Sarah brings vast geographical expansion experience in international markets. Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets ("Medison"), is proud to announce the joining of Sarah ...
Petach Tikvah, Israel (ots/PRNewswire) - With this latest expansion, Medison's global footprint is now extended across Israel, Central and Eastern Europe, Canada, Asia-Pacific and Latin America, offering patients in international markets improved access to highly innovative therapies. Medison Pharma ("Medison"), a global pharma company focused on providing access to ...
Petach Tikvah, Israel (ots/PRNewswire) - Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today the expansion of its partnership with Albireo to a multi-regional agreement to commercialize Odevixibat in ...
Petach Tikvah, Israel (ots/PRNewswire) - KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United States and the European Union Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly ...
Petach Tikvah, Israel (ots/PRNewswire) - Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today an exclusive multi-regional agreement with argenx to commercialize efgartigimod in 14 countries, including ...
Petach Tikvah, Israel (ots/PRNewswire) - The latest geographic growth increases Medison's global footprint across 25 countries in four continents, further strengthening its commercial offering Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients ...